Agomelatine Synthesis via Phthalimide Intermediate

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for synthesizing agomelatine are inefficient due to high pressure requirements, costly starting materials, and complex multi-step processes, making them unsuitable for industrial production.

Innovation Solution

A new process involving the reaction of 7-methoxy-1-naphthylethyl alkyl- or aryl-sulfonate with potassium phthalimide in a polar aprotic solvent to produce N-[2-(7-methoxy-1-naphthyl)ethyl]phthalimide, followed by alkaline hydrolysis and acylation to obtain agomelatine, which simplifies the synthesis and eliminates high-pressure conditions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If traditional multi-step synthesis methods are used, then agomelatine can be produced, but the process requires high pressure (300 atm), costly starting materials, and complex purification steps

Engineering Contradiction:
Improveproduct purityVSAvoidprocess complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The synthesis process is divided into distinct modular steps: (1) formation of the phthalimide intermediate from 7-methoxy-1-naphthylethyl alkyl- or aryl-sulfonate and potassium phthalimide in polar aprotic solvent, (2) alkaline hydrolysis of the phthalimide to give the amine, and (3) acylation of the amine to produce agomelatine. This segmentation allows each step to be optimized independently and eliminates the need for high-pressure hydrogenation equipment.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

N-[2-(7-methoxy-1-naphthyl)ethyl]phthalimide is introduced as a key intermediate that simplifies the synthesis pathway. The phthalimide group serves as a protective and reactive intermediate that can be easily formed and decomposed, replacing the need for complex multi-step sequences and high-pressure conditions in traditional methods.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of manufacture

If traditional hydrogenation methods are used, then the target functional group can be formed, but high pressure (300 atm) is required which is difficult to generate in industrial production

Engineering Contradiction:
Improveindustrial feasibilityVSAvoidhydrogenation pressure
Core Design Contradiction:
Ease of manufactureVSStress or pressure

Solution Approach 1:

The high-pressure mechanical hydrogenation system is replaced with a chemical substitution approach using potassium phthalimide as a nitrogen source. The phthalimide intermediate is formed under normal pressure conditions and then hydrolyzed to provide the amine group, eliminating the need for high-pressure hydrogenation equipment and making the process suitable for industrial-scale production.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Quantity of substance

If 7-methoxy-1-tetralone is used as starting material, then the synthesis can proceed, but the starting material is costly and not easily available

Engineering Contradiction:
Improvestarting material availabilityVSAvoidmanufacturing cost
Core Design Contradiction:
Quantity of substanceVSEase of manufacture

Solution Approach 1:

The starting material is changed from 7-methoxy-1-tetralone to 7-methoxy-1-naphthylethyl alkyl- or aryl-sulfonate. This parameter change in the starting material structure enables the use of readily available, inexpensive materials while maintaining the ability to produce agomelatine through the simplified phthalimide-based synthesis pathway.

Inventive Principle:
Principle #35Parameter changes

4Manufacturing precision

If traditional saponification methods are used, then the synthesis can be completed, but purification is so difficult that column chromatography is necessitated

Engineering Contradiction:
Improveproduct purityVSAvoidpurification efficiency
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The difficult purification step is extracted and eliminated by using the phthalimide intermediate approach. The phthalimide group provides a handle for easy separation and purification through standard techniques, avoiding the need for column chromatography and significantly improving purification efficiency and productivity.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This process reduces the number of steps, eliminates the need for high-pressure equipment, and uses readily available materials, resulting in a more efficient and cost-effective method for producing agomelatine with high purity suitable for industrial-scale production.

Implementation Method 1

reacting 7-methoxy-1-naphthylethyl alkyl- or aryl-sulfonate with potassium phthalimide in a polar aprotic solvent

Methodology Applied
Scientific EffectNucleophilic substitution: Chemical Bonding

Implementation Method 2

alkaline hydrolysis of N-[2-(7-methoxy-1-naphthyl)ethyl]phthalimide

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Implementation Method 3

2-(7-methoxy-1-naphthyl)ethyl amine or its salt is reacted with an acylating agent, to give agomelatine

Methodology Applied
Scientific EffectAcylation: Chemical Bonding

Data Source

PatentUS8653281B2Process for the manufacture of agomelatine and its intermediate
Publication Date: 2014.02.18 NHWA PHARMA CORPORATION
  • US8653281B2 patent drawing
  • US8653281B2 patent drawing
  • US8653281B2 patent drawing

AI summary

A process for the manufacture of agomelatine and its intermediate N-[2-(7-methoxy- 1-naphthy)ethyl]phthalimide is provided and inclues reacting 7-methoxy-1-naphthyl ethanol (III) with benzenesulfonyl chloride to obtain 7-methoxy-1 -naphthylethyl benzene sulfonate (IV), which is reacted with potassium phthalimide to produce N-[2-(7-methoxy-1-naphthy)ethyl]phthalimide (II); and subjecting N-[2-(7-methoxy-1-naphthy)ethyl]phthalimide (II) to alkaline hydrolysis and acetylation, to obtain agomelatine.